Brianna Gerber
VP of FP&A and Investor Relations
Head of Investor Relations
CFO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Niagen Bioscience, Inc. (NAGE) | Former Chief Financial Officer | $215,000 | $450,969 |
| 2023 | Niagen Bioscience, Inc. (NAGE) | Former Chief Financial Officer | $325,000 | $691,588 |
| 2022 | Niagen Bioscience, Inc. (NAGE) | Former Chief Financial Officer | $269,096 | $842,384 |
Executive changes
Earnings-call appearances
-
Niagen Bioscience, Inc. Q1 FY2024 Earnings Call2024-05-08
Niagen Bioscience, Inc. (NAGE)
-
Niagen Bioscience, Inc. Q4 FY2023 Earnings Call2024-03-06
Niagen Bioscience, Inc. (NAGE)
-
Niagen Bioscience, Inc. Q3 FY2023 Earnings Call2023-11-08
Niagen Bioscience, Inc. (NAGE)
-
Niagen Bioscience, Inc. Q2 FY2023 Earnings Call2023-08-09
Niagen Bioscience, Inc. (NAGE)
-
Niagen Bioscience, Inc. Q1 FY2023 Earnings Call2023-05-10
Niagen Bioscience, Inc. (NAGE)
-
Niagen Bioscience, Inc. Q4 FY2022 Earnings Call2023-03-08
Niagen Bioscience, Inc. (NAGE)
-
Niagen Bioscience, Inc. Q3 FY2022 Earnings Call2022-11-02
Niagen Bioscience, Inc. (NAGE)
-
Niagen Bioscience, Inc. Q1 FY2022 Earnings Call2022-05-12
Niagen Bioscience, Inc. (NAGE)
-
Niagen Bioscience, Inc. Q4 FY2021 Earnings Call2022-03-09
Niagen Bioscience, Inc. (NAGE)
-
Niagen Bioscience, Inc. Q3 FY2021 Earnings Call2021-11-03
Niagen Bioscience, Inc. (NAGE)
-
Niagen Bioscience, Inc. Q2 FY2021 Earnings Call2021-08-03
Niagen Bioscience, Inc. (NAGE)
-
Niagen Bioscience, Inc. Q1 FY2021 Earnings Call2021-05-06
Niagen Bioscience, Inc. (NAGE)
-
Niagen Bioscience, Inc. Q4 FY2020 Earnings Call2021-03-10
Niagen Bioscience, Inc. (NAGE)
-
Niagen Bioscience, Inc. Q3 FY2020 Earnings Call2020-11-04
Niagen Bioscience, Inc. (NAGE)
-
Niagen Bioscience, Inc. Q2 FY2020 Earnings Call2020-08-06
Niagen Bioscience, Inc. (NAGE)
-
Niagen Bioscience, Inc. Q1 FY2020 Earnings Call2020-05-11
Niagen Bioscience, Inc. (NAGE)